Cedric "Jamie" Rutland, MD - An Animated Exploration of Chronic Fibrosing Interstitial Lung Disease: From Diagnosis to Management in the Era of Antifibrotic Therapy - a podcast by PVI, PeerView Institute for Medical Education
from 2021-06-23T18:00
Go online to PeerView.com/QXS860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in interstitial lung disease discusses the diagnosis of and novel and emerging therapies to treat chronic fibrosing interstitial lung disease. Upon completion of this accredited CE activity, participants should be better able to: Recognize risk factors associated with the development of chronic fibrosing interstitial lung disease (CF-ILD), such as having a connective tissue disease, chronic hypersensitivity pneumonitis, and unclassifiable ILD, Identify signs and symptoms indicative of CF-ILD to allow for earlier diagnosis, pulmonary monitoring, and treatment, Discuss the latest clinical data on efficacy and safety for novel and emerging therapies to treat CF-ILD, Develop individualized treatment plans for patients with CF-ILD based on the latest expert recommendations and clinical evidence.
Further episodes of PeerView Clinical Pharmacology CME/CNE/CPE Audio Podcast
Further podcasts by PVI, PeerView Institute for Medical Education